These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6787734)

  • 1. Effect of sex differences on subcellular distribution of aflatoxin in F-344 rats treated with various risk-modifying factors.
    Mainigi KD; Campbell TC
    Toxicol Appl Pharmacol; 1981 Apr; 58(2):236-43. PubMed ID: 6787734
    [No Abstract]   [Full Text] [Related]  

  • 2. A mechanism of inhibition of aflatoxin B1-DNA binding in the liver by phenobarbital pretreatment of rats.
    Lotlikar PD; Raj HG; Bohm LS; Ho LL; Jhee EC; Tsuji K; Gopalan P
    Cancer Res; 1989 Feb; 49(4):951-7. PubMed ID: 2492210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vivo disposition of aflatoxin B1 in rat liver.
    Ewaskiewicz JI; Devlin TM; Ch'ih JJ
    Biochem Biophys Res Commun; 1991 Sep; 179(2):1095-100. PubMed ID: 1910338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolism of aflatoxin B1 by hepatocytes isolated from rats following the in vivo administration of some xenobiotics.
    Metcalfe SA; Neal GE
    Carcinogenesis; 1983 Aug; 4(8):1007-12. PubMed ID: 6409441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sex difference and dietary protein level on the binding of aflatoxin B1 to rat liver chromatin proteins in vivo.
    Prince LO; Campbell TC
    Cancer Res; 1982 Dec; 42(12):5053-9. PubMed ID: 6814751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal diethylstilbestrol treatment alters aflatoxin B1-DNA adduct concentrations in adult rats.
    Lamartiniere CA
    J Biochem Toxicol; 1990; 5(1):41-6. PubMed ID: 2119435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of neonatal phenobarbital exposure on aflatoxin b1 disposition in adult rats.
    Faris RA; Campbell TC
    Cancer Res; 1983 Jun; 43(6):2576-83. PubMed ID: 6406048
    [No Abstract]   [Full Text] [Related]  

  • 8. Interindividual differences in the activation of two hepatic carcinogens to mutagens by human liver.
    Harries GC; Boobis AR; Collier N; Davies DS
    Hum Toxicol; 1986 Jan; 5(1):21-6. PubMed ID: 3081427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA binding and adduct formation of aflatoxin B1 in cultured human and animal tracheobronchial and bladder tissues.
    Stoner GD; Daniel FB; Schenck KM; Schut HA; Sandwisch DW; Gohara AF
    Carcinogenesis; 1982; 3(11):1345-8. PubMed ID: 6817939
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of chronic exposure to aflatoxin B1 and aflatoxin M1 on the in vivo covalent binding of aflatoxin B1 to hepatic macromolecules.
    Loury DN; Hsieh DP
    J Toxicol Environ Health; 1984; 13(4-6):575-87. PubMed ID: 6436500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excision of aflatoxin B1-imidazole ring opened guanine adducts from DNA by formamidopyrimidine-DNA glycosylase.
    Chetsanga CJ; Frenette GP
    Carcinogenesis; 1983 Aug; 4(8):997-1000. PubMed ID: 6409445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic basis of the species difference to aflatoxin B1 induced hepatotoxicity.
    O'Brien K; Moss E; Judah D; Neal G
    Biochem Biophys Res Commun; 1983 Jul; 114(2):813-21. PubMed ID: 6411093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivo.
    Swenson DH; Lin JK; Miller EC; Miller JA
    Cancer Res; 1977 Jan; 37(1):172-81. PubMed ID: 187331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aflatoxin-DNA adduct formation in chronically dosed rats fed a choline-deficient diet.
    Schrager TF; Newberne PM; Pikul AH; Groopman JD
    Carcinogenesis; 1990 Jan; 11(1):177-80. PubMed ID: 2104783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential binding of aflatoxin B1 to the transcriptionally active regions of rat liver nucleolar chromatin in vivo and in vitro.
    Yu FL
    Carcinogenesis; 1983; 4(7):889-93. PubMed ID: 6409439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aflatoxin B1: correlations of patterns of metabolism and DNA modification with biological effects.
    Croy RG; Essigmann JM; Wogan GN
    Basic Life Sci; 1983; 24():49-62. PubMed ID: 6407467
    [No Abstract]   [Full Text] [Related]  

  • 17. Differences in the effect of phenobarbital treatment on the in vitro metabolism of aflatoxin and aniline by duck and rat livers.
    Patterson DS; Roberts BA
    Biochem Pharmacol; 1971 Dec; 20(12):3377-83. PubMed ID: 5132884
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of pre-treatment with phenobarbitone on the activation of aflatoxin B1 by rat liver.
    Neal GE; Godoy HM
    Chem Biol Interact; 1976 Aug; 14(3-4):279-89. PubMed ID: 954146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aflatoxin-macromolecular adducts in the hepatic and nonhepatic tissues of F-344 male rats.
    Mainigi KD
    Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):329-32. PubMed ID: 6878870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of aflatoxin B1 binding to hepatic DNA by dehydroepiandrosterone in vivo.
    Prasanna HR; Lu MH; Beland FA; Hart RW
    Carcinogenesis; 1989 Dec; 10(12):2197-200. PubMed ID: 2531635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.